Interaction
Checker
Select the substances you intend to use together and the drug classes you use; See common known interactions and security alerts.
Nootropics
The class of medication you are using (if any)
- medium riskDMAE
DMAE - dikkat
Fisman 1981: A double-blind placebo-controlled trial studied 27 people with Alzheimer's disease. 6 of 13 in the drug group withdrew within 5 weeks because of side effects; no significant benefit was found. Reported problems included drowsiness, slowing, increased confusion and mild blood-pressure elevation. The abstract does not verify randomization; 6/13 is not the adverse-event rate for all users. It does not justify self-directed dose reduction or timing advice. Fisher 2001: Mouse embryos exposed in vitro to 250–750 µM DMAE for 26 hours developed facial and neural-tube defects. This is not an oral-dose trial in pregnant humans; human risk magnitude or a safe dose cannot be calculated. It gives no reassurance for self-use in pregnancy. Use with neurological/psychiatric illness or medicines needs clinical assessment; missing interaction records do not mean safe.
- medium riskHuperzine A
Huperzin A - dikkat
Huperzine A’s cholinergic adverse effects are not confined to overdose; nausea, vomiting and reduced heart rate can occur. Combining it with prescription cholinesterase inhibitors can add effects. Cycling has not been shown to prevent or reliably resolve adverse effects. Dose and duration require assessment by a health professional.
- medium riskPiracetam
Piracetam - dikkat
Piracetam is renally eliminated; dose adjustment is needed with impaired renal function and severe renal failure is a contraindication. Cerebral hemorrhage and Huntington chorea are contraindications. Bleeding risk, anticoagulants/antiplatelets and planned surgery require medical review. Abrupt withdrawal in myoclonus can trigger seizures.
- medium riskvinpocetine
Vinposetin - dikkat
FDA’s 2019 warning advises pregnant women and women who could become pregnant not to take vinpocetine because of miscarriage or fetal-development risks. Its 2016 dietary-supplement definition position is a separate issue. Anticoagulants, blood-pressure medicines and bleeding risk need medical review.
- medium riskPiracetam + Ginkgo Biloba + Vinposetin
Added bleeding tendency
The effects of multiple anticoagulant substances are additive; avoid high doses.
These results are screening warnings. Severity describes a potential concern, not its probability or the certainty of clinical evidence. Some rules extrapolate from mechanisms or drug classes; an absent warning does not establish safety.
NCCIH: Using Dietary Supplements Wisely · FDA: Mixing Medications and Dietary Supplements Can Endanger Your Health
⚠ Medical Alert
This tool shows only known general interactions; it is not exhaustive and does not replace medical advice. A "No interaction found" result does not mean a combination is safe. If you take prescription medication or have a health condition, always consult your doctor or pharmacist before trying any combination.